Literature DB >> 22382045

Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study.

Ingrid Havnes1, Anne Bukten, Michael Gossop, Helge Waal, Per Stangeland, Thomas Clausen.   

Abstract

BACKGROUND: Although opioid maintenance treatment (OMT) has been found to reduce crime, less is known about its associations with violent crime. This study investigates changes in violent crime convictions prior to, during, and after OMT, and examines the relationship between violent crime convictions prior to OMT with the risk of violent and non-violent crime convictions during treatment.
METHODS: The cohort comprised all who started OMT (n=3221) in Norway between 1997 and 2003. Treatment data were cross linked with the national Crime Registry. Convictions for violent crime 3 years prior to, during, and after treatment were studied.
RESULTS: Violent crime rates were significantly reduced during OMT compared with before treatment, for both men and women. The rate of convictions for violent crime during OMT was halved amongst those who remained in treatment. The reduction was less pronounced for those who left treatment: for this group, the rate of violent convictions after OMT was higher than before treatment. The risk of convictions for violent and non-violent crime during OMT was highest for those with violent convictions prior to treatment.
CONCLUSIONS: Violent crime is reduced during OMT. Screening for violent behaviour and violence risk assessment should be implemented in the treatment system.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22382045     DOI: 10.1016/j.drugalcdep.2012.02.005

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Medication-Assisted Treatment and Violent Outcomes in Community-Based Offenders with Alcohol and Drug Use Problems.

Authors:  Sarah L Desmarais; Julie S Gray; Candalyn B Rade; Amy M Cohn; Stephen Doherty; Kevin Knight
Journal:  Psychol Violence       Date:  2016-03-24

2.  The role of substance use and morality in violent crime - a qualitative study among imprisoned individuals in opioid maintenance treatment.

Authors:  Ingrid Amalia Havnes; Thomas Clausen; Christina Brux; Anne-Lise Middelthon
Journal:  Harm Reduct J       Date:  2014-08-20

3.  Comorbid opioid use is undertreated among forensic patients with schizophrenia.

Authors:  Kristiina Kivimies; Eila Repo-Tiihonen; Hannu Kautiainen; Jari Tiihonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-06

4.  The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.

Authors:  Viktor Mravčík; Barbara Janíková; Barbora Drbohlavová; Petr Popov; Alessandro Pirona
Journal:  Harm Reduct J       Date:  2018-12-04

5.  Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study.

Authors:  Benjamin S Teeter; Mary M Thannisch; Bradley C Martin; Nickolas D Zaller; Duane Jones; Cynthia L Mosley; Geoffrey M Curran
Journal:  Explor Res Clin Soc Pharm       Date:  2021-05-08

6.  'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.

Authors:  Ingrid Amalia Havnes; Thomas Clausen; Anne-Lise Middelthon
Journal:  Harm Reduct J       Date:  2013-10-16

7.  A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study.

Authors:  Anne Bukten; Jo Røislien; Svetlana Skurtveit; Helge Waal; Michael Gossop; Thomas Clausen
Journal:  BMC Psychiatry       Date:  2013-10-16       Impact factor: 3.630

8.  Accounting for individual differences and timing of events: estimating the effect of treatment on criminal convictions in heroin users.

Authors:  Jo Røislien; Thomas Clausen; Jon Michael Gran; Anne Bukten
Journal:  BMC Med Res Methodol       Date:  2014-05-17       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.